What Defines a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Below is a list of notable value stocks in the healthcare sector:
- 9 Meters Biopharma NMTR - P/E: 7.82
- SunLink Health Systems SSY - P/E: 2.52
- Antares Pharma ATRS - P/E: 9.79
- Forte Biosciences FBRX - P/E: 0.47
- Bio-Rad Laboratories BIO - P/E: 5.62
9 Meters Biopharma looks to be undervalued. It possesses an EPS of -0.03, which has not changed since last quarter (Q1). 9 Meters Biopharma does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
SunLink Health Systems has reported Q4 earnings per share at 0.64, which has increased by 1014.29% compared to Q3, which was -0.07. SunLink Health Systems does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Antares Pharma saw an increase in earnings per share from 0.02 in Q1 to 0.03 now. Antares Pharma does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
Forte Biosciences's earnings per share for Q2 sits at -0.43, whereas in Q1, they were at -0.36. Forte Biosciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
This quarter, Bio-Rad Laboratories experienced a decrease in earnings per share, which was 5.21 in Q1 and is now 3.54. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.